SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH H impact

Vivani Medical Reports Third Quarter 2026 Financial Results and Provides Business Update

Top-line results for SLIM-1™, the first-in-human Phase 1 trial of NPM-139, Vivani's miniature, ultra-long-acting semaglutide implant under development for chronic weight management, are anticipated for announcement later this weekCortigent-ClearOne merger is awaiting final regulatory approvals allo…

VANI
SquawkNews Desk

Related stories

Centrica and Equinor Advance to Next Round of Uniper Sale Centrica and Equinor are in the next round of Germany’s Uniper sale, Bloomberg News reports. M impact | MNA | Nov 14, 2026, 10:23 AM UTC Pricol Promoters to Sell 38.51% Stake in Autotech Unit to Warburg Pincus Pricol said its board approved the sale of promoters’ entire 38.51% shareholding in Pricol Autotech Limited to Warburg Pincus. M impact | MNA | Nov 14, 2026, 02:29 AM UTC High Arctic Energy Services Agrees to Go-Private Sale to Newport Capital High Arctic Energy Services entered into a definitive acquisition agreement and announced its intent to make a cash distribution to shareholders. M impact | MNA | Nov 14, 2026, 01:01 AM UTC Hall Chadwick Acquisition Sets Shareholder Vote on REEcycle Merger Hall Chadwick Acquisition announced a shareholder meeting to vote on its merger with REEcycle. M impact | MNA | Nov 13, 2026, 09:49 PM UTC Surgery Partners Raises HealthSpan Merger Price to $25 per Share Surgery Partners raised its merger price for HealthSpan to $25 per share after a competing bid. M impact | MNA | Nov 13, 2026, 05:53 PM UTC GCI Completes Quintillion Acquisition to Consolidate Alaska Fibre Networks GCI completed its acquisition of Quintillion, consolidating Alaska fibre networks. M impact | MNA | Nov 13, 2026, 05:53 PM UTC